The most common conditions

Title Effect Research Type Journal Year
Intravenous Delta-9-Tetrahydrocannabinol to Prevent Postoperative Nausea and Vomiting: A Randomized Controlled Trial. NONE humans Anesthesia and analgesia 2015
Delta-9-tetrahydrocannabinol delays the gastric emptying of solid food in humans: a double-blind, randomized study. positive humans Alimentary pharmacology & therapeutics 1999
Cannabis and cancer chemotherapy: a comparison of oral delta-9-THC and prochlorperazine. positive humans Cancer 1982
Antiemetic effect of delta 9-tetrahydrocannabinol in chemotherapy-associated nausea and emesis as compared to placebo and compazine. positive humans Journal of clinical pharmacology 1981
A prospective evaluation of delta-9-tetrahydrocannabinol as an antiemetic in patients receiving adriamycin and cytoxan chemotherapy. NONE humans Cancer 1981
Antiemetic effect of tetrahydrocannabinol. Compared with placebo and prochlorperazine in chemotherapy-associated nausea and emesis. positive humans Archives of internal medicine 1980
delta 9-Tetrahydrocannabinol for refractory vomiting induced by cancer chemotherapy. positive humans JAMA 1980
Efficacy of tetrahydrocannabinol in patients refractory to standard antiemetic therapy. positive humans Investigational new drugs 1988
Delta-9-tetrahydrocannabinol as an antiemetic for patients receiving cancer chemotherapy. A comparison with prochlorperazine and a placebo. positive humans Annals of internal medicine 1979
delta 9-Tetrahydrocannabinol (THC) as an antiemetic in patients treated with cancerchemotherapy; a double-blind cross-over trial against placebo. positive humans Veterinary and human toxicology 1979
Delata-9-tetrahydrocannabinol as an antiemetic in cancer patients receiving high-dose methotrexate. A prospective, randomized evaluation. positive humans Annals of internal medicine 1979